
Modella AI is a biomedical artificial intelligence company based in Boston, Massachusetts, focused on revolutionizing patient care through generative AI for medical imaging. The company develops innovative AI models that integrate multimodal biomarker data to enhance diagnostic, prognostic, and therapeutic workflows. Their key products include PathChat, an AI copilot for pathology case consultation and report generation, and Judith, an AI agent for automating AI model development in biomedical image analysis and scientific discovery. Modella AI aims to empower healthcare professionals with AI systems for precise assessments and uncover novel biomarkers for therapeutics, thereby improving patient outcomes globally. The company has received significant press coverage from outlets like STAT News, Nature, and Venture Beat, and their PathChat product has received FDA Breakthrough Device Designation.

Modella AI is a biomedical artificial intelligence company based in Boston, Massachusetts, focused on revolutionizing patient care through generative AI for medical imaging. The company develops innovative AI models that integrate multimodal biomarker data to enhance diagnostic, prognostic, and therapeutic workflows. Their key products include PathChat, an AI copilot for pathology case consultation and report generation, and Judith, an AI agent for automating AI model development in biomedical image analysis and scientific discovery. Modella AI aims to empower healthcare professionals with AI systems for precise assessments and uncover novel biomarkers for therapeutics, thereby improving patient outcomes globally. The company has received significant press coverage from outlets like STAT News, Nature, and Venture Beat, and their PathChat product has received FDA Breakthrough Device Designation.